Neuroone Medical Technologies (NMTC) Return on Assets (2011 - 2026)

Neuroone Medical Technologies has disclosed Return on Assets across 15 years of filings, most recently posting 0.01% for Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
• Return on Assets fell to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q3 2025 and bottomed at 0.02% in Q3 2024.
• The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.01%.
• Year-over-year, Return on Assets declined 1 bps in 2022 and climbed 2 bps in 2025.
• Neuroone Medical Technologies' Return on Assets stood at 0.01% in 2022, then slumped by 144 bps to 0.02% in 2023, then soared by 37 bps to 0.01% in 2024, then soared by 42 bps to 0.01% in 2025, then retreated by 22 bps to 0.01% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.